Volume 23, Issue 3 (8-2024)
TB 2024, 23(3): 107-122 |
Back to browse issues page
Ethics code: IR.ZAUMS.REC.1401.218
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Zanganeh Baygi M, peyvand M, Mirani Bahabadi F, Noormohamadi S N. Explaining the Experiences of the Reasons for Non-Adherence to Treatment of Leukemia Cancer Patients in the Least Privileged Province of the Country: A Qualitative Study. TB 2024; 23 (3) :107-122
URL: http://tbj.ssu.ac.ir/article-1-3624-en.html
URL: http://tbj.ssu.ac.ir/article-1-3624-en.html
Zahedan University of Medical Sciences , mp.peyvand@yahoo.com
Full-Text [PDF 605 kb]
(169 Downloads)
| Abstract (HTML) (245 Views)
Full-Text: (485 Views)
Explaining the Experiences of the Reasons for Non-Adherence to Treatment of Leukemia Cancer Patients in the Least Privileged Province of the Country: A Qualitative Study
Mehdi Zanganeh Baygi (Ph.D.)1, Mostafa peyvand (MS.c.)2, Faezeh Mirani Bahabadii (M.Sc.)3 , Sayedeh Narges Noormohamadi (M.Sc.)4
1.Associate Professor, Department of Health Services Management, Zahedan University of Medical Sciences, Zahedan, Iran
2.Corresponding author :MS.c. Student of Epidemiology,Student Research committee, Zahedan University of Medical Sciences, Zahedan, Iran. Email: Mp.peyvand@yahoo.com Tel: 09159412965
3.MS.c Student of Epidemiology ,Student Research committee, Zahedan University of Medical Sciences, Zahedan, Iran
4.MS.c.Student of Health Services Management, Student research committee, Zahedan University of Medical Sciences, Zahedan, Iran
Abstract
Introduction: One of the most important challenges in cancer patients is the long treatment period, and as a result, non-compliance with the treatment, considering the cultural and indigenous context of Sistan and Baluchistan province, the importance of this position is felt more. Therefore, the present study was conducted with the aim of explaining the experiences of non-adherence to treatment in Leukemia cancer patients.
Methods: This cross-sectional study was conducted qualitatively with a content analysis approach via a purpose-based sampling method on 34 leukemia cancer patients with a mean age of 46±7 in 2022. The data collection tool was a semi-structured interview guide. All interviews were recorded and implemented daily on paper. Finally, the data was coded using conventional content analysis method.
Results: In this study, 17 women and 17 men were included in the study. 9 (26/5%) of them were more than 50 years old. After summarizing and coding the issues raised by the participants, 114 initial codes were obtained, five main themes (financial problems, lack of access to medical services, distrust of the health system and treatment, drug interactions and lack of motivation to continue treatment) and 10 sub-themes were extracted.
Conclusion: It can be concluded that adherence to drug regimen in cancer patients is a complex issue that depends on many factors. The financial and spiritual support of the government, increasing insurance coverage, and developing infrastructure for better access of patients to medicines and medical centers are among the implementation suggestions of this study.
Keywords: Hospital, Cancer, Leukemia patients, Contract content analysis
References
1-Demir B, Kocamer Sahin S, Altındağ A & et al. Substance use profile, treatment compliance, treatment outcomes and related factors in probation: a retrospective file review. J Ethn Subst Abuse. 2021;20(3):490-505.
2-Di Pace B, Padley RH. Enhancing treatment compliance in breast cancer patients: A multi-faceted approach. J Surg Oncol. 2024;130(1):38-39.
3-Tewari S, Ferrando CA. Breast Cancer Screening Referral Patterns and Compliance in Transgender Male Patients. Transgend Health. 2024;9(2):136-142.
4-Zhang M, Zhang Y, Guo L & et al. Trends in colorectal cancer screening compliance and incidence among 60- to 74-year-olds in China. Cancer Med. 2024;13(8):e7133.
5-Bossi P, Pietrzyńska T, Margarit Ferri C & et al. Compliance with the breakthrough cancer pain European guidelines and impact on patients' quality of life: an observational prospective study. Front Pain Res (Lausanne). 2024;5:1388837.
6-Stasiewicz B, Wadolowska L, Biernacki M & et al. Compliance with the WCRF/AICR Recommendations in Qualitative Adaptation and the Occurrence of Breast Cancer: A Case-Control Study. Cancers (Basel). 2024;16(2):468.
7-Wang Q, Du N. Relationship between kinesiophobia and quality of life among patients with breast cancer-related lymphedema: Chain-mediating effect of self-care and functional exercise compliance. Asia Pac J Oncol Nurs. 2023;11(1):100346.
8-Zhang Y, Yao W, Zhou J & et al. Impact of surgical compliance on survival prognosis of patients with ovarian cancer and associated influencing factors: A propensity score matching analysis of the SEER database. Heliyon. 2024;10(13):e33639.
9-Rawicz-Pruszyński K, Tsilimigras DI, Endo Y & et al. Improved guideline compliance and textbook oncologic outcomes among patients undergoing multimodal treatment and minimally invasive surgery for locally advanced gastric cancer. J Gastrointest Surg. 2024;28(1):10-17.
10-Evangeliou AE, Spilioti MG, Vassilakou D, & et al. Restricted Ketogenic Diet Therapy for Primary Lung Cancer With Metastasis to the Brain: A Case Report. Cureus. 2022;14(8):e27603.
11-Trayes KP, Cokenakes SEH. Breast Cancer Treatment. Am Fam Physician. 2021;104(2):171-178.
12-Martínez-Reyes I, Chandel NS. Cancer metabolism: looking forward. Nat Rev Cancer. 2021;21(10):669-680.
13-Faramarzi S, Kiani B, Faramarzi S, & et al. Cancer patterns in Iran: a gender-specific spatial modelling of cancer incidence during 2014-2017. BMC Cancer. 2024;24(1):191.
14-Cullin N, Azevedo Antunes C, Straussman R, & et al. Microbiome and cancer. Cancer Cell. 2021;39(10):1317-1341.
15-Sandhu S, Moore CM, Chiong E,& et al. Prostate cancer. Lancet. 2021 18;398(10305):1075-1090.
16-Hoseinzadeh M, Sa'adAbadi Z, Maleki Kambakhsh S & et al. Dentists' lived experience of providing dental care during the COVID-19 pandemic: A qualitative study in Mashhad, Iran. Front Oral Health. 2023; 4:1095240.
17-Hayat AA, Keshavarzi MH, Zare S, et al. Challenges and opportunities from the COVID-19 pandemic in medical education: a qualitative study. BMC Med Educ. 2021;21(1):247.
18-Khammarnia M, Setoodehzadeh F, Ansari-Moghaddam A & et al. Household financial contribution to the health system after Iran's Health Transformation Plan. Rural Remote Health. 2020;20(1):5495.
19-O'Reilly D, McLaughlin R, Ronayne C, & et al. Cost and public reimbursement of cancer medicines in the UK and the Republic of Ireland. Ir J Med Sci. 2023;192(2):541-548.
20-Garaszczuk R, Yong JHE, Sun Z, de Oliveira C. The Economic Burden of Cancer in Canada from a Societal Perspective. Curr Oncol. 2022;29(4):2735-2748.
21-Mousavizadeh S N, Ashktorab T, Ahmadi F, & et al. Evaluation of barriers to adherence to therapy in patients with diabetes. J Diabetes Nurs 2016; 4 (3) :94-108
22-Berini CR, Bonilha HS, Simpson AN. Impact of Community Health Workers on Access to Care for Rural Populations in the United States: A Systematic Review. J Community Health. 2022;47(3):539-553.
23-Clemente KAP, Silva SVD, Vieira GI, & et al. Barriers to the access of people with disabilities to health services: a scoping review. Rev Saude Publica. 2022; 56:64.
24-Khammarnia M, Hashemi Karghash Z, Peyvand M, & et al. A Survey on Trust to Hospital Services after Health Transformation Plan. Payesh 2020; 19 (3) :243-254
25-Wei D, Xu A, Wu X. The mediating effect of trust on the relationship between doctor-patient communication and patients' risk perception during treatment. Psych J. 2020;9(3):383-391.
26-Seyed Fatemi N, Rafii F, Hajizadeh E, Modanloo M. Psychometric properties of the adherence questionnaire in patients with chronic disease: A mix method study. Koomesh 2018; 20 (2) :179-191
27-Mauro AG, Hunter K, Salloum FN. Cardiac complications of cancer therapies. Adv Cancer Res. 2022; 155:167-214.
28-Willems RAL, Winckers K, Biesmans C, & et al. Evolving data on cardiovascular complications in cancer. Thromb Res. 2022;213 Suppl 1: S87-S94.
29-Paly VF, Dasari A, Hubbard J, & et al. Adverse event costs of systemic therapies for metastatic colorectal cancer previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy and biologics in the US. J Comp Eff Res. 2024;13(8):e240084
30-Rendle KA, Saia CA, Vachani A, & et al. Rates of Downstream Procedures and Complications Associated With Lung Cancer Screening in Routine Clinical Practice : A Retrospective Cohort Study. Ann Intern Med. 2024 Jan;177(1):18-28.
31-Magill N, Walker J, Symeonides S, Gourley C, Hobbs H, Rosenstein D, Frost C, Sharpe M. Depression and anxiety during the year before death from cancer. J Psychosom Res. 2022.
Mehdi Zanganeh Baygi (Ph.D.)1, Mostafa peyvand (MS.c.)2, Faezeh Mirani Bahabadii (M.Sc.)3 , Sayedeh Narges Noormohamadi (M.Sc.)4
1.Associate Professor, Department of Health Services Management, Zahedan University of Medical Sciences, Zahedan, Iran
2.Corresponding author :MS.c. Student of Epidemiology,Student Research committee, Zahedan University of Medical Sciences, Zahedan, Iran. Email: Mp.peyvand@yahoo.com Tel: 09159412965
3.MS.c Student of Epidemiology ,Student Research committee, Zahedan University of Medical Sciences, Zahedan, Iran
4.MS.c.Student of Health Services Management, Student research committee, Zahedan University of Medical Sciences, Zahedan, Iran
Abstract
Introduction: One of the most important challenges in cancer patients is the long treatment period, and as a result, non-compliance with the treatment, considering the cultural and indigenous context of Sistan and Baluchistan province, the importance of this position is felt more. Therefore, the present study was conducted with the aim of explaining the experiences of non-adherence to treatment in Leukemia cancer patients.
Methods: This cross-sectional study was conducted qualitatively with a content analysis approach via a purpose-based sampling method on 34 leukemia cancer patients with a mean age of 46±7 in 2022. The data collection tool was a semi-structured interview guide. All interviews were recorded and implemented daily on paper. Finally, the data was coded using conventional content analysis method.
Results: In this study, 17 women and 17 men were included in the study. 9 (26/5%) of them were more than 50 years old. After summarizing and coding the issues raised by the participants, 114 initial codes were obtained, five main themes (financial problems, lack of access to medical services, distrust of the health system and treatment, drug interactions and lack of motivation to continue treatment) and 10 sub-themes were extracted.
Conclusion: It can be concluded that adherence to drug regimen in cancer patients is a complex issue that depends on many factors. The financial and spiritual support of the government, increasing insurance coverage, and developing infrastructure for better access of patients to medicines and medical centers are among the implementation suggestions of this study.
Keywords: Hospital, Cancer, Leukemia patients, Contract content analysis
References
1-Demir B, Kocamer Sahin S, Altındağ A & et al. Substance use profile, treatment compliance, treatment outcomes and related factors in probation: a retrospective file review. J Ethn Subst Abuse. 2021;20(3):490-505.
2-Di Pace B, Padley RH. Enhancing treatment compliance in breast cancer patients: A multi-faceted approach. J Surg Oncol. 2024;130(1):38-39.
3-Tewari S, Ferrando CA. Breast Cancer Screening Referral Patterns and Compliance in Transgender Male Patients. Transgend Health. 2024;9(2):136-142.
4-Zhang M, Zhang Y, Guo L & et al. Trends in colorectal cancer screening compliance and incidence among 60- to 74-year-olds in China. Cancer Med. 2024;13(8):e7133.
5-Bossi P, Pietrzyńska T, Margarit Ferri C & et al. Compliance with the breakthrough cancer pain European guidelines and impact on patients' quality of life: an observational prospective study. Front Pain Res (Lausanne). 2024;5:1388837.
6-Stasiewicz B, Wadolowska L, Biernacki M & et al. Compliance with the WCRF/AICR Recommendations in Qualitative Adaptation and the Occurrence of Breast Cancer: A Case-Control Study. Cancers (Basel). 2024;16(2):468.
7-Wang Q, Du N. Relationship between kinesiophobia and quality of life among patients with breast cancer-related lymphedema: Chain-mediating effect of self-care and functional exercise compliance. Asia Pac J Oncol Nurs. 2023;11(1):100346.
8-Zhang Y, Yao W, Zhou J & et al. Impact of surgical compliance on survival prognosis of patients with ovarian cancer and associated influencing factors: A propensity score matching analysis of the SEER database. Heliyon. 2024;10(13):e33639.
9-Rawicz-Pruszyński K, Tsilimigras DI, Endo Y & et al. Improved guideline compliance and textbook oncologic outcomes among patients undergoing multimodal treatment and minimally invasive surgery for locally advanced gastric cancer. J Gastrointest Surg. 2024;28(1):10-17.
10-Evangeliou AE, Spilioti MG, Vassilakou D, & et al. Restricted Ketogenic Diet Therapy for Primary Lung Cancer With Metastasis to the Brain: A Case Report. Cureus. 2022;14(8):e27603.
11-Trayes KP, Cokenakes SEH. Breast Cancer Treatment. Am Fam Physician. 2021;104(2):171-178.
12-Martínez-Reyes I, Chandel NS. Cancer metabolism: looking forward. Nat Rev Cancer. 2021;21(10):669-680.
13-Faramarzi S, Kiani B, Faramarzi S, & et al. Cancer patterns in Iran: a gender-specific spatial modelling of cancer incidence during 2014-2017. BMC Cancer. 2024;24(1):191.
14-Cullin N, Azevedo Antunes C, Straussman R, & et al. Microbiome and cancer. Cancer Cell. 2021;39(10):1317-1341.
15-Sandhu S, Moore CM, Chiong E,& et al. Prostate cancer. Lancet. 2021 18;398(10305):1075-1090.
16-Hoseinzadeh M, Sa'adAbadi Z, Maleki Kambakhsh S & et al. Dentists' lived experience of providing dental care during the COVID-19 pandemic: A qualitative study in Mashhad, Iran. Front Oral Health. 2023; 4:1095240.
17-Hayat AA, Keshavarzi MH, Zare S, et al. Challenges and opportunities from the COVID-19 pandemic in medical education: a qualitative study. BMC Med Educ. 2021;21(1):247.
18-Khammarnia M, Setoodehzadeh F, Ansari-Moghaddam A & et al. Household financial contribution to the health system after Iran's Health Transformation Plan. Rural Remote Health. 2020;20(1):5495.
19-O'Reilly D, McLaughlin R, Ronayne C, & et al. Cost and public reimbursement of cancer medicines in the UK and the Republic of Ireland. Ir J Med Sci. 2023;192(2):541-548.
20-Garaszczuk R, Yong JHE, Sun Z, de Oliveira C. The Economic Burden of Cancer in Canada from a Societal Perspective. Curr Oncol. 2022;29(4):2735-2748.
21-Mousavizadeh S N, Ashktorab T, Ahmadi F, & et al. Evaluation of barriers to adherence to therapy in patients with diabetes. J Diabetes Nurs 2016; 4 (3) :94-108
22-Berini CR, Bonilha HS, Simpson AN. Impact of Community Health Workers on Access to Care for Rural Populations in the United States: A Systematic Review. J Community Health. 2022;47(3):539-553.
23-Clemente KAP, Silva SVD, Vieira GI, & et al. Barriers to the access of people with disabilities to health services: a scoping review. Rev Saude Publica. 2022; 56:64.
24-Khammarnia M, Hashemi Karghash Z, Peyvand M, & et al. A Survey on Trust to Hospital Services after Health Transformation Plan. Payesh 2020; 19 (3) :243-254
25-Wei D, Xu A, Wu X. The mediating effect of trust on the relationship between doctor-patient communication and patients' risk perception during treatment. Psych J. 2020;9(3):383-391.
26-Seyed Fatemi N, Rafii F, Hajizadeh E, Modanloo M. Psychometric properties of the adherence questionnaire in patients with chronic disease: A mix method study. Koomesh 2018; 20 (2) :179-191
27-Mauro AG, Hunter K, Salloum FN. Cardiac complications of cancer therapies. Adv Cancer Res. 2022; 155:167-214.
28-Willems RAL, Winckers K, Biesmans C, & et al. Evolving data on cardiovascular complications in cancer. Thromb Res. 2022;213 Suppl 1: S87-S94.
29-Paly VF, Dasari A, Hubbard J, & et al. Adverse event costs of systemic therapies for metastatic colorectal cancer previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy and biologics in the US. J Comp Eff Res. 2024;13(8):e240084
30-Rendle KA, Saia CA, Vachani A, & et al. Rates of Downstream Procedures and Complications Associated With Lung Cancer Screening in Routine Clinical Practice : A Retrospective Cohort Study. Ann Intern Med. 2024 Jan;177(1):18-28.
31-Magill N, Walker J, Symeonides S, Gourley C, Hobbs H, Rosenstein D, Frost C, Sharpe M. Depression and anxiety during the year before death from cancer. J Psychosom Res. 2022.
Type of Study: Research |
Subject:
Nursing
Received: 2024/05/2 | Accepted: 2024/09/10 | Published: 2024/08/31
Received: 2024/05/2 | Accepted: 2024/09/10 | Published: 2024/08/31
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
